Cargando…
Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients
Immunosuppression can lead to hepatitis B virus (HBV) reactivation in hepatitis B core antigen antibodies (anti-HBc) positive patients, especially those undergoing chemotherapy, although there is limited data on solid organ recipients, especially lung transplantation. Our aim was to analyze the risk...
Autores principales: | Álvarez-López, Patricia, Riveiro-Barciela, Mar, Oleas-Vega, Diana, Flores-Cortes, Claudia, Román, Antonio, Perelló, Manel, Berastegui, Cristina, Castells, Lluis, Esteban, Rafael, Buti, María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478413/ https://www.ncbi.nlm.nih.gov/pubmed/32118794 http://dx.doi.org/10.1097/MD.0000000000019407 |
Ejemplares similares
-
Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease: A meta-analysis
por: Coppola, Nicola, et al.
Publicado: (2016) -
Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B
por: Roade, Luisa, et al.
Publicado: (2021) -
Cirrhosis, Liver Transplantation and HIV Infection Are Risk Factors Associated with Hepatitis E Virus Infection
por: Riveiro-Barciela, Mar, et al.
Publicado: (2014) -
Bone demineralization in a cohort of Egyptian pediatric liver transplant recipients: Single center pilot study
por: Kotb, Magd A., et al.
Publicado: (2022) -
Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B
por: Buti, Maria, et al.
Publicado: (2021)